Eradicating Helicobacter pylori infection can prevent gastric cancer

Analysis

The claim resonates because many people associate H. pylori only with ulcers and are unaware of its role in cancer development. Media emphasis on a Nobel laureate’s endorsement adds credibility, leading the public to view eradication as a simple cure. However, the nuance is that the preventive effect is strongest when treatment occurs before intestinal metaplasia or atrophic changes develop; once advanced precancerous lesions are present, eradication offers limited benefit. Additionally, rising antibiotic resistance, as highlighted in the article, can undermine treatment success, meaning that a blanket recommendation without local resistance data could be misleading. Understanding these limits helps readers appreciate why screening programs must be paired with appropriate antibiotic stewardship and follow‑up testing to achieve the promised cancer‑prevention impact.